Cg Pharmaceuticals
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4 Orinda Way Ste 100D, Orinda, Californi...Phone Number
(925) 257-7036Website
www.cgpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cg Pharmaceuticals
CG Pharmaceuticals is a wholly-owned US subsidiary of CrystalGenomics, located in Orinda, CA. Founded in November 2006, the company is dedicated to clinical research and development specifically for CrystalGenomics. Its efforts are focused on advancing innovative pharmaceutical solutions. The intended clients are primarily associated with the broader operations of CrystalGenomics.Explore more
Cg Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cg Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cg Pharmaceuticals
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Cg Pharmaceuticals recently announced quarterly report
Cg Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Cg Pharmaceuticals has new funding data
Check out if Cg Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Cg Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Cg Pharmaceuticals launches new products
Check if Cg Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Cg Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Cg Pharmaceuticals
Compare insights from companies similar to Cg Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cg Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cg Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cg Pharmaceuticals.
Cg Pharmaceuticals Tech Stack
A closer look at the technologies used by Cg Pharmaceuticals
Cg Pharmaceuticals News & Media
CG Pharmaceuticals Prepares to Showcase Its Ongoing Phase 2 Study for Ivaltinostat in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
ORINDA, Calif., May 29, 2024 /PRNewswire/ -- CG Pharmaceuticals, a company dedicated to advancing innovative therapies to improve the lives of patients with cancer, prepares to showcase its advancements in metastatic PDAC therapy. The study design of a randomized multi-center Phase 2 US...CG Pharmaceuticals, Inc. to Present at the 2024 ASCO Annual Meeting in Chicago on June 1st
ORINDA, Calif., May 6, 2024 /PRNewswire/ -- CG Pharmaceuticals, a late-stage clinical biopharmaceutical company specializing in metastatic pancreatic ductal adenocarcinoma (PDAC) maintenance therapy (NCT05249101), will feature one of our investigators, Dr. Christos Fountzilas from Roswell...CG Pharmaceuticals Announces the Commencement of Phase 2 Study for Metastatic Pancreatic Cancer
ORINDA, Calif., Nov. 17, 2023 /PRNewswire/ -- CG Pharmaceuticals announces the commencement of Phase 2 study for metastatic pancreatic ductal adenocarcinoma (PDAC) with the recommended Phase 2 dose (RP2D) of ivaltinostat (ClinicalTrials.gov ID NCT05249101). CG Pharmaceuticals Announces...CG Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Ivaltinostat for the Treatment of Pancreatic Adenocarcinoma
ORINDA, Calif. and SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- CG Pharmaceuticals, Inc. announced the first patient dosed with the ivaltinostat and capecitabine combination therapy for the Phase 1b/2 pancreatic adenocarcinoma (PDAC) maintenance study. Commencement of treatment for...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cg Pharmaceuticals
Sign Up For FreeTo access detailed company insights
CG Pharmaceuticals is a wholly-owned US subsidiary of CrystalGenomics, located in Orinda, CA. Founded in November 2006, the company is dedicated to clinical research and development specifically for CrystalGenomics. Its efforts are focused on advancing innovative pharmaceutical solutions. The intended clients are primarily associated with the broad... Read More
